Immunovia AB (publ)

IMMVF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$25-$20-$19-$30
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$10$3-$7-$1
Other Non-Cash$13-$1$1$2
Operating Cash Flow-$16-$18-$24-$28
Investing Activities
PP&E Inv.-$6$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$5$0$0$0
Investing Cash Flow-$1$0$0$0
Financing Activities
Debt Repay.$2-$0-$1-$1
Stock Issued$0$10$37$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$2$10$37-$1
Forex Effect$0-$0-$0$0
Net Chg. in Cash-$0-$8$12-$29
Supplemental Information
Beg. Cash$3$38$25$54
End Cash$3$29$38$25
Free Cash Flow-$22-$18-$24-$28
Immunovia AB (publ) (IMMVF) Financial Statements & Key Stats | AlphaPilot